BILL · 2021–22 SESSION
HB 1346: Children/treatment & testing
Concerning treatment and genetic testing for children with seizures, neurological symptoms, and other physical symptoms.
Did not pass Did not pass · died in committee
- IntroducedJan 21, 2021
- Out of committeestopped here
- Passed House
- Passed Senate
- Governor
- Law
- Prime sponsor
- Pat Sullivan (D-47)
- Introduced
- January 21, 2021 in the House
- Last action
- January 10, 2022
AN ACT Relating to treatment and genetic testing for children with seizures, neurological symptoms, and other physical symptoms;
Sponsors
Prime sponsor: Pat Sullivan (D-47)
2 co-sponsors (2 Democrats, 0 Republicans)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- By resolution, reintroduced and retained in present status.
- First reading, referred to Health Care & Wellness (Not Officially read and referred until adoption of Introduction report).
HB 1346 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- HB 1346 (2025–26) Cannabis industry
- HB 1346 (2023–24) Purple star award
- HB 1346 (2019–20) Lead exposure in youth
- HB 1346 (2017–18) Nurse in school setting
- HB 1346 (2015–16) Hunting opportunity/st. land
- HB 1346 (2013–14) Tipped employee wages
- HB 1346 (2011–12) Tax law changes
- HB 1346 (2009–10) Lead-containing products